Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data

RM Islam, RJ Bell, S Green, MJ Page… - The lancet Diabetes & …, 2019 - thelancet.com
Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …

[HTML][HTML] The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women

AH Clayton, I Goldstein, NN Kim, SE Althof… - Mayo Clinic …, 2018 - Elsevier
Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …

The impact of the COVID-19 pandemic on women's reproductive health

N Phelan, LA Behan, L Owens - Frontiers in endocrinology, 2021 - frontiersin.org
Background The COVID-19 pandemic has profoundly affected the lives of the global
population. It is known that periods of stress and psychological distress can affect women's …

[图书][B] Come as you are: The surprising new science that will transform your sex life

E Nagoski - 2015 - books.google.com
An essential exploration of why and how women's sexuality works—based on
groundbreaking research and brain science—that will radically transform your sex life into …

Female sexual health: barriers to optimal outcomes and a roadmap for improved patient–clinician communications

SA Kingsberg, J Schaffir, BM Faught… - Journal of women's …, 2019 - liebertpub.com
Background: Although sexual health can be considered a vital sign for overall health,
several barriers prevent women from receiving proper medical counseling, support, and/or …

[HTML][HTML] Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials

SA Kingsberg, AH Clayton, D Portman… - Obstetrics & …, 2019 - journals.lww.com
OBJECTIVE: To evaluate the safety and efficacy of bremelanotide for the treatment of
premenopausal women with hypoactive sexual desire disorder. METHODS: Two identical …

Sexual well-being after menopause: an international menopause society white paper

JA Simon, SR Davis, SE Althof, P Chedraui… - …, 2018 - Taylor & Francis
Sexual well-being frequently declines following the menopause transition and can be
associated with significant personal and relationship distress. This distress is the hallmark of …

[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors

R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial

BA Tompkins, DL DiFede, A Khan… - … Series A: Biomedical …, 2017 - academic.oup.com
Background Aging frailty, characterized by decreased physical and immunological
functioning, is associated with stem cell depletion. Human allogeneic mesenchymal stem …

[HTML][HTML] The International Society for the Study of Women's sexual health process of Care for the Identification of sexual concerns and problems in women

SJ Parish, SR Hahn, SW Goldstein, A Giraldi… - Mayo Clinic …, 2019 - Elsevier
Sexual problems are common in women of all ages. Despite their frequency and impact,
female sexual dysfunctions (FSDs) are often unrecognized and untreated in clinical settings …